The same goes for HDAC1, HDAC2, HDAC10, SIRT3, SIRT6 in prostate cancer (Figure 8D); HDAC2, HDAC10 and SIRT6 in renal (Figure 8E) and skin cancers (Figure 9A); HDAC10, SIRT3, SIRT6, SIRT7 in stomach cancer (Figure 9B); HDAC2, HDAC5, HDAC10, SIRT3, SIRT6 in testicular cancer (Figure 9C); HDAC1, HDAC4, HDAC10, SIRT 3, SIRT5, SIRT6, SIRT7 in thyroid cancer (Figure 9D) and HDAC1, HDAC2, HDAC10, SIRT3, SIRT6, SIRT7 in urothelial cancer (UC) (Figure 9E) [43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60]. Here, HDAC2 is linked to skin neoplasm.